Chris Green MP, a former engineer in the life sciences sector, chaired an important debate on the future of medical research this week.
He brought together industry experts, politicians, researchers and patients to discuss the importance of continued investment in medical research in securing our place as one of the leading countries in the field.
The government has already committed to increasing investment in Research and Development, pledging to contribute 2.4% of GDP to the field by 2027. This will not only create and support world leading companies in their latest medical advances but also creates exciting new job opportunities for those leaving school and university.
As Chair of the All Party Parliamentary Group (APPG) on Medical Research and Vice-Chair of the APPG for Life Sciences, Mr Green led the debate about where this funding should come from and where it should be directed.
Mr Green said: “It was fantastic to chair this joint APPG on Medical Research and APPG for Life Sciences event, which saw a wide range of organisations and groups come together to discuss the importance of medical research and the future of the field.
“During the event, we discussed the need for increasing investment in research and development and the importance of developing a skilled research and development workforce.
“We also discussed ways that we can continue to work across borders post-Brexit, so that people from around the world can participate in our future science innovations.”
Mr Green was also joined by Barbara Domayne-Hayman, Francis Crick Institute Entrepreneur in Residence, Jane Taylor, Versus Arthritis Patient Insight Partner and representatives from the HM Treasury and AstraZeneca at the important event.
